Journal
ADVANCED MATERIALS
Volume 34, Issue 52, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202201051
Keywords
drug delivery; medical imaging; micro-; nanorobotics; tumor diagnosis; tumor therapy
Categories
Funding
- National Key R&D Program of China [2021YFA1101500]
- National Natural Science Foundation of China [22074047, 21775049]
Ask authors/readers for more resources
Cancer is a difficult-to-treat disease due to its high mortality rate and lack of effective diagnostic and treatment tools. Recent advancements in micro-/nanorobot technology provide opportunities for the development of cancer theragnostic platforms, which can enable precise drug delivery and improved permeation.
Cancer is one of the most intractable diseases owing to its high mortality rate and lack of effective diagnostic and treatment tools. Advancements in micro-/nanorobot (MNR)-assisted sensing, imaging, and therapeutics offer unprecedented opportunities to develop MNR-based cancer theragnostic platforms. Unlike ordinary nanoparticles, which exhibit Brownian motion in biofluids, MNRs overcome viscous resistance in an ultralow Reynolds number (Re << 1) environment by effective self-propulsion. This unique locomotion property has motivated the advanced design and functionalization of MNRs as a basis for next-generation cancer-therapy platforms, which offer the potential for precise distribution and improved permeation of therapeutic agents. Enhanced barrier penetration, imaging-guided operation, and biosensing are additionally studied to enable the promising cancer-related applications of MNRs. Herein, the recent advances in MNR-based cancer therapy are comprehensively addresses, including actuation engines, diagnostics, medical imaging, and targeted drug delivery; promising research opportunities that can have a profound impact on cancer therapy over the next decade is highlighted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available